121 related articles for article (PubMed ID: 12011981)
1. Inhibition of HIV-1 LTR-driven in vitro transcription by molecular hybrids based on peptide nucleic acids mimicking the NF-kappaB binding site.
Mischiati C; Borgatti M; Feriotto G; Rutigliano C; Breda L; Bianchi N; Gambari R
Int J Mol Med; 2002 Jun; 9(6):633-9. PubMed ID: 12011981
[TBL] [Abstract][Full Text] [Related]
2. Peptide nucleic acid-DNA decoy chimeras targeting NF-kappaB transcription factors: Induction of apoptosis in human primary osteoclasts.
Penolazzi L; Borgatti M; Lambertini E; Mischiati C; Finotti A; Romanelli A; Saviano M; Pedone C; Piva R; Gambari R
Int J Mol Med; 2004 Aug; 14(2):145-52. PubMed ID: 15254756
[TBL] [Abstract][Full Text] [Related]
3. Computational procedures to explain the different biological activity of DNA/DNA, DNA/PNA and PNA/PNA hybrid molecules mimicking NF-kappaB binding sites.
Saviano M; Romanelli A; Bucci E; Pedone C; Mischiati C; Bianchi N; Feriotto G; Borgatti M; Gambari R
J Biomol Struct Dyn; 2000 Dec; 18(3):353-62. PubMed ID: 11149512
[TBL] [Abstract][Full Text] [Related]
4. Decoy oligodeoxyribonucleotides and peptide nucleic acids-DNA chimeras targeting nuclear factor kappa-B: inhibition of IL-8 gene expression in cystic fibrosis cells infected with Pseudomonas aeruginosa.
Gambari R; Borgatti M; Bezzerri V; Nicolis E; Lampronti I; Dechecchi MC; Mancini I; Tamanini A; Cabrini G
Biochem Pharmacol; 2010 Dec; 80(12):1887-94. PubMed ID: 20615393
[TBL] [Abstract][Full Text] [Related]
5. Molecular interactions with nuclear factor kappaB (NF-kappaB) transcription factors of a PNA-DNA chimera mimicking NF-kappaB binding sites.
Romanelli A; Pedone C; Saviano M; Bianchi N; Borgatti M; Mischiati C; Gambari R
Eur J Biochem; 2001 Dec; 268(23):6066-75. PubMed ID: 11733000
[TBL] [Abstract][Full Text] [Related]
6. Extending recognition by peptide nucleic acids (PNAs): binding to duplex DNA and inhibition of transcription by tail-clamp PNA-peptide conjugates.
Kaihatsu K; Shah RH; Zhao X; Corey DR
Biochemistry; 2003 Dec; 42(47):13996-4003. PubMed ID: 14636068
[TBL] [Abstract][Full Text] [Related]
7. Defining the peptide nucleic acids (PNA) length requirement for PNA binding-induced transcription and gene expression.
Wang G; Jing K; Balczon R; Xu X
J Mol Biol; 2001 Nov; 313(5):933-40. PubMed ID: 11700050
[TBL] [Abstract][Full Text] [Related]
8. Reactive oxygen species activate HIV long terminal repeat via post-translational control of NF-kappaB.
Pyo CW; Yang YL; Yoo NK; Choi SY
Biochem Biophys Res Commun; 2008 Nov; 376(1):180-5. PubMed ID: 18765232
[TBL] [Abstract][Full Text] [Related]
9. Interaction of the human NF-kappaB p52 transcription factor with DNA-PNA hybrids mimicking the NF-kappaB binding sites of the human immunodeficiency virus type 1 promoter.
Mischiati C; Borgatti M; Bianchi N; Rutigliano C; Tomassetti M; Feriotto G; Gambari R
J Biol Chem; 1999 Nov; 274(46):33114-22. PubMed ID: 10551882
[TBL] [Abstract][Full Text] [Related]
10. Peptide nucleic acid (PNA) binding-mediated gene regulation.
Wang G; Xu XS
Cell Res; 2004 Apr; 14(2):111-6. PubMed ID: 15115611
[TBL] [Abstract][Full Text] [Related]
11. Ras-responsiveness of the HIV-1 LTR requires RBF-1 and RBF-2 binding sites.
Bell B; Sadowski I
Oncogene; 1996 Dec; 13(12):2687-97. PubMed ID: 9000143
[TBL] [Abstract][Full Text] [Related]
12. Binding of hybrid molecules containing pyrrolo [2,1-c][1,4]benzodiazepine (PBD) and oligopyrrole carriers to the human immunodeficiency type 1 virus TAR-RNA.
Mischiati C; Finotti A; Sereni A; Boschetti S; Baraldi PG; Romagnoli R; Feriotto G; Jeang KT; Bianchi N; Borgatti M; Gambari R
Biochem Pharmacol; 2004 Feb; 67(3):401-10. PubMed ID: 15037192
[TBL] [Abstract][Full Text] [Related]
13. PNA-nitrogen mustard conjugates are effective suppressors of HER-2/neu and biological tools for recognition of PNA/DNA interactions.
Zhilina ZV; Ziemba AJ; Nielsen PE; Ebbinghaus SW
Bioconjug Chem; 2006; 17(1):214-22. PubMed ID: 16417271
[TBL] [Abstract][Full Text] [Related]
14. Cationic liposomes as delivery systems for double-stranded PNA-DNA chimeras exhibiting decoy activity against NF-kappaB transcription factors.
Borgatti M; Breda L; Cortesi R; Nastruzzi C; Romanelli A; Saviano M; Bianchi N; Mischiati C; Pedone C; Gambari R
Biochem Pharmacol; 2002 Aug; 64(4):609-16. PubMed ID: 12167479
[TBL] [Abstract][Full Text] [Related]
15. Cooperative strand invasion of supercoiled plasmid DNA by mixed linear PNA and PNA-peptide chimeras.
Lundin KE; Ge R; Svahn MG; Törnquist E; Leijon M; Brandén LJ; Smith CI
Biomol Eng; 2004 Apr; 21(2):51-9. PubMed ID: 15113558
[TBL] [Abstract][Full Text] [Related]
16. Differential regulation of HIV-1 clade-specific B, C, and E long terminal repeats by NF-kappaB and the Tat transactivator.
Roof P; Ricci M; Genin P; Montano MA; Essex M; Wainberg MA; Gatignol A; Hiscott J
Virology; 2002 Apr; 296(1):77-83. PubMed ID: 12036319
[TBL] [Abstract][Full Text] [Related]
17. Influenza virus activates human immunodeficiency virus type-1 gene expression in human CD4-expressing T cells through an NF-kappaB-dependent pathway.
Sun J; Bergeron M; Barbeau B; Boivin G; Tremblay MJ
Clin Immunol; 2005 Feb; 114(2):190-8. PubMed ID: 15639653
[TBL] [Abstract][Full Text] [Related]
18. Activation of the human immunodeficiency virus type I long terminal repeat by 1 alpha,25-dihydroxyvitamin D3.
Nevado J; Tenbaum SP; Castillo AI; Sánchez-Pacheco A; Aranda A
J Mol Endocrinol; 2007 Jun; 38(6):587-601. PubMed ID: 17556530
[TBL] [Abstract][Full Text] [Related]
19. Resistance of decoy PNA-DNA chimeras to enzymatic degradation in cellular extracts and serum.
Borgatti M; Romanelli A; Saviano M; Pedone C; Lampronti I; Breda L; Nastruzzi C; Bianchi N; Mischiati C; Gambari R
Oncol Res; 2003; 13(5):279-87. PubMed ID: 12688679
[TBL] [Abstract][Full Text] [Related]
20. Strand invasion of mixed-sequence B-DNA by acridine-linked, gamma-peptide nucleic acid (gamma-PNA).
Rapireddy S; He G; Roy S; Armitage BA; Ly DH
J Am Chem Soc; 2007 Dec; 129(50):15596-600. PubMed ID: 18027941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
